Navigation Links
PharmAthene Strengthens Scientific Leadership and Program Management for Future Growth
Date:1/10/2011

gement responsibilities for developing vaccines from late discovery through licensure.  Previously, Ms. Linna was the Vice President of Project Management at Emergent Biosolutions, where she was responsible for unifying multiple, local project management functions under one project management office, and standardizing the practices, processes, roles and responsibilities of project managers and project leaders. Previously, she served as Director of Project Management at Human Genome Sciences and prior thereto was employed at Merck, most recently as Associate Director of Project Planning and Management with experience taking product candidates from early development to licensure.  Ms. Linna holds a B.S. in Biology/Chemistry; a M.A. in Biology, and a M.S. in biostatistics from Western Michigan University.

Dr. Kevin Connolly, who was recently appointed to the position of Senior Program Director for rPA-based anthrax vaccines, began his career in the biopharmaceutical industry in 1982, and brings vast experience in the development of both small molecule and genomics-based drugs, as well as vaccine development with a focus in anthrax, influenza, RSV and VZV.  Dr. Connolly joined PharmAthene from Novavax Inc, where he was the Director of Product Development and Preclinical Project Leader for RSV and VZV vaccine development, as well as seasonal and pandemic influenza vaccine.  Prior to this, Dr. Connolly worked for Emergent Biosolutions as Director of Product Development, where he served as a Project Leader for the next generation anthrax vaccine (rPA) and adjuvanted AVA (Anthrax Vaccine Absorbed) programs.   Previously, he was Senior Scientist in the Department of Pharmacology and a Project Manager at Human Genome Sciences.  In addition, he spent eight years with Glaxo Inc., as a Research Investigator.  Dr. Connolly holds a B.A. in Natural Science from Johns Hopkins University and a M.S. in Biology from Virginia Tech.  He
'/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. PharmAthene Receives FDA Clearance to Reinitiate Clinical Testing of Valortim®
2. PharmAthene Reports Third Quarter 2010 Financial and Operational Results
3. PharmAthene Receives Four Therapeutic Discovery Project Grants Totaling Approximately $850,000
4. PharmAthene Announces Pricing of $15 Million Public Offering
5. PharmAthene Announces Proposed Common Stock Offering
6. PharmAthene Announces $3.9 Million Registered Direct Offering
7. PharmAthene CEO To Participate on Biosecurity Panel at the 2010 BIO International Conference
8. PharmAthene Appoints Mitchel Sayare, Ph.D. to the Companys Board of Directors
9. PharmAthene Reports Year-End 2009 Financial and Operational Results and Provides Update On Ongoing Litigation With SIGA Technologies
10. PharmAthene to Provide Update on SparVax(TM) Contract Modification Suspension During Year-End 2009 Financial and Operational Results Conference Call on Tuesday March 23, 2010
11. PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... “Never say, ‘I cannot do ... Department of Physics, advises young women pursuing careers ... SPIE Women in Optics 18-month planner ... ask questions.” , In the annual planner, women ... ranging from university professor and laboratory researcher to ...
(Date:12/17/2014)... Beach, CA (PRWEB) December 17, 2014 ... Inc. to provide a larger packaged waste water treatment ... in King Abdullah Economic City (KAEC). Two years ago ... EMAAR’s Jeddah Gate Development, serving two residential towers with ... capacity is over a quarter million gallons per day ...
(Date:12/17/2014)... Menlo Park, CA (PRWEB) December 17, 2014 ... Inc. announces today that it has entered into ... Daniels Midland Company (ADM) to apply DNA2.0’s proprietary ... industrial enzyme engineering process. , “We are extremely ... our ProteinGPS engineering platform. This proprietary bioengineering ...
(Date:12/17/2014)...  United Therapeutics Corporation (NASDAQ: UTHR ) ... changes to Martine Rothblatt , Ph.D,s compensation program. ... United Therapeutics announced the promotion of Roger Jeffs ... David Zaccardelli , Pharm.D. to Executive Vice President ... Dr. Rothblatt,s title will change from Chairman and Chief ...
Breaking Biology Technology:Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 2Network, Multitask, Persevere: SPIE Women in Optics Planner Subjects Share from Experience 3ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 2United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 3United Therapeutics Corporation Announces Executive Promotions and CEO Compensation Change 4
... (NYSE: TMO ) announced that it will host ... starting at 9:00 a.m. (EDT), at The,Grand Hyatt New ... City., The meeting will feature presentations by members ... an in-depth company,overview as well as expectations for future ...
... CITY, May 1 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: ... company focused on,endocrine therapy and oncology, will announce ... market open on Wednesday, May 7,2008. The Company ... discuss these,results later that same day at 4:00 ...
... Raffaele Hospital in Milan and Northeast Georgia Medical Center in ... Gainesville, ... ... ST. LOUIS, May 1 Stereotaxis, Inc. (Nasdaq:,STXS) announced today the first ever bi-directional ...
Cached Biology Technology:Thermo Fisher Scientific to Host Analyst Meeting 2Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey(TM) Network 2Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey(TM) Network 3Stereotaxis Highlights a Transatlantic Arrhythmia Procedure Collaboration With the Odyssey(TM) Network 4
(Date:12/3/2014)... 2, 2014   Marvin Test Solutions , ... solutions for military, aerospace, and manufacturing organizations, today ... successful TS-900 PXI semiconductor test platform . ... high-end systems to customers at a fraction of ... traditional ATE. "Our semiconductor customers ...
(Date:11/21/2014)... , Nov. 20, 2014 Strict laws against ... are piloting the North American and European automotive sector ... growing, gesture recognition systems that are intuitive and able ... in the industry. New analysis from ... Recognition Market in Europe and ...
(Date:11/18/2014)... Nov. 17, 2014   News ... collaborate to develop The Partners Data Lake, an ... Partners Data Lake will allow researcher and clinicians ... treatment and the lives of patients , ... clinical activities across the Partners system, breaking down ...
Breaking Biology News(10 mins):Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 2Marvin Test Solutions Brings New Capabilities to PXI-Based Semiconductor Test with TS-960 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 2Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 3Gesture Recognition Intensifies with the Rise of In-car Smartphone Integration, Says Frost & Sullivan 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 2Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 3Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 4Partners HealthCare and EMC Unite to Solve Health Care's Toughest Challenges Using Big Data 5
... , University of Iowa biologist Daniel Eberl and his colleagues have ... to the battery in your car. And if that isn,t ... by studying a similar auditory system in fruit fliesand by making ... the mechanism of hearing resembles a battery, you need to know ...
... -- The ability to focus and switch tasks readily ... following brain concussions suffered by high school athletes, according ... Research team members, in an interview, said the discovery ... than current practices dictate to lower the risk of ...
... Researchers have discovered a new compound that restores ... aureus (MRSA), an otherwise dangerous bacterial infection. The ... cells but which is essential to bacterial survival. ... of Illinois and the University of California, San Diego, ...
Cached Biology News:UI researcher learns mechanism of hearing is similar to car battery 2Cognitive deficits from concussions still present after 2 months 2Cognitive deficits from concussions still present after 2 months 3New compound overcomes drug-resistant Staph infection in mice 2New compound overcomes drug-resistant Staph infection in mice 3
... Processing mini Tray (3 per pack), ... staining and blot processing.Automated staining of ... proteins and nucleic acid analysis.Prepares blots ... chromogenic detection.Programmable control of protocol, solution, ...
... 1 g. High quality kits ... preparation that give consistent and ... and tissues.Clean up samples from ... Accurately quantitate protein for first-dimension ...
GOAT ANTI CARICA PAPAYA PAPAIN...
PAb to Hu-IFN-Alpha/Beta R2 [(IFNAR2) CD118], Rabbit Serum, neutralizing Binds to but does not neutralize human interferon alpha/beta receptor...
Biology Products: